Inventor · disambiguated record
Tomoki Naoe
Also filed as: NAOE TOMOKI
9 granted patents·3 pending applications·66 citations·filing 1999–2017
85Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD2KYOWA HAKKO KIRIN CO LTD2KYOWA HAKKO KOGYO KK2CELL TECHNOLOGIES INC T1FUJIFILM CORP1
Top patents by PatentIndex Score
12 records- 0193US7956060B2Pyrimidine derivative compoundKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 7, 2011·37 cites·8 claims
- 0279US9987278B2Pharmaceutical composition for treating FLT3 mutation-positive cancer, mutant FLT3 inhibitor and uses thereofFUJIFILM CORP·Filed 2017·Granted Jun 5, 2018·6 cites·18 claims
- 0379US7470717B2Indazole derivativesKYOWA HAKKO KOGYO KK·Filed 2004·Granted Dec 30, 2008·14 cites·15 claims
- 0464US7858333B2Method for screening candidate compounds for antitumor drugCHUGAI PHARMACEUTICAL CO LTD·Filed 2006·Granted Dec 28, 2010·1 cites·6 claims
- 0558US7919517B2Indazole derivativesKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Apr 5, 2011·0 cites·11 claims
- 0658US2011318828A1Kit for preparation of antigen-specific cytotoxic lymphocytesSUZUKI SUSUMU·Filed 2009·Application pending·0 cites
- 0751US7125659B1Method and screening candidate compounds for drug against tumorCHUGAI PHARMACEUTICAL CO LTD·Filed 1999·Granted Oct 24, 2006·8 cites·2 claims
- 0851US2014127805A1Method for preparation of antigen-specific cytotoxic t lymphocytesCELL TECHNOLOGIES INC T·Filed 2013·Application pending·0 cites
- 0947US8426131B2Method for screening candidate compounds for antitumor drugKIYOI HITOSHI·Filed 2010·Granted Apr 23, 2013·0 cites·1 claims
- 1045US8496927B2CD20 negatively converted B-cell malignant lymphoma cell line and utilization thereofNAOE TOMOKI·Filed 2007·Granted Jul 30, 2013·0 cites·7 claims
- 1145US2006281789A1Protein kinase inhibitorsKYOWA HAKKO KOGYO KK·Filed 2004·Application pending·0 cites
- 1240US10828377B2Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemiaUNIV TOKYO·Filed 2016·Granted Nov 10, 2020·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →